January 2005

The annual Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The IL-36 inhibitor is being explored for additional inflammatory skin conditions, aiming to expand treatment options for underserved patient groups.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins.

Delayed cerebral ischemia is a leading complication in the severe form of stroke known as subarachnoid hemorrhage and can result in long-term neurological damage, disability, or death.